menu search

Mersana therapeutics to present at upcoming investor conferences

CAMBRIDGE, Mass., May 24, 2023 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on d...

May 24, 2023, 12:00 pm

Exact sciences positioned for a solid year after ‘impressive' 1q, broker says

Exact Sciences (NASDAQ:EXAS) Corporation earned a price target raise from Canaccord Genuity (TSX:CF, LSE:CF) after the molecular diagnostics company ...

May 16, 2023, 2:43 pm

Bridgebio pharma to present updated data from its bbp-812 canavan disease gene therapy program at the 2023 american society of gene and cell therapy (asgct) annual meeting

PALO ALTO, Calif., May 15, 2023 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage ...

May 15, 2023, 11:30 am

Bridgebio pharma to present updated data from its bbp-812 canavan disease gene therapy program at the 2023 american society of gene and cell therapy (asgct) annual meeting

PALO ALTO, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage ...

May 15, 2023, 7:30 am

Viracta therapeutics to present at the rbc capital markets global healthcare conference

SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and preve...

May 11, 2023, 4:05 pm

Hookipa pharma reports first quarter 2023 financial results and recent business highlights

HOOKIPA on track to report Phase 2 data on HB-200 for head and neck cancer in combination with pembrolizumab in 2Q 2023 Phase 1 clinical trials initia...

May 11, 2023, 11:01 am

Glycomimetics: an asymmetric opportunity that could change hematology

Rarely, a developmental biotech comes along with new chemistry that potentially becomes curative via transplantation. Blood ...

May 10, 2023, 12:20 pm

Cti biopharma skyrockets on acquisition by sobi

CTI BioPharma shares added almost 85% on the news that the company would be acquired by Stockholm-based hematology and immunology leader Swedish Orpha...

May 10, 2023, 11:13 am

Swedish orphan biovitrum to acquire cti biopharma in a deal valued at $1.7 billion

Swedish Orphan Biovitrum AB SE:SOBI on Wednesday announced that it has entered into an agreement to acquire U.S.-based CTI BioPharma Corp. CTIC in a d...

May 10, 2023, 2:26 am

Aim immunotech to discuss first quarter 2023 financial results on may 16, 2023 and host conference call and webcast

OCALA, Fla., May 09, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company foc...

May 9, 2023, 12:50 pm

Blueprint is well-positioned to capitalize on ism market (maintain 'buy')

Blueprint Medicines focuses on developing precision therapies for genomically defined cancers and blood...

May 9, 2023, 2:28 am

Olema oncology announces upcoming poster presentation at the 2023 esmo breast cancer annual congress

SAN FRANCISCO, May 08, 2023 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage bio...

May 8, 2023, 11:06 am

Prophase labs’ linebacker-1 cancer therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers, including l

Garden City, NY, May 03, 2023 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next-generation biotech, genomics and diagno...

May 3, 2023, 12:30 pm

Delcath systems to host first quarter 2023 results

NEW YORK , May 3, 2023 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary an...

May 3, 2023, 8:30 am

Can-fite biopharma spikes on pancreatic cancer inhibition finding

Can-Fite BioPharma Ltd. NYSEAMERICAN: CANF is an Israel-based biotechnology firm that develops small-molecule therapeutic treatments for ...

May 2, 2023, 1:12 pm

Cti biopharma to report first quarter 2023 financial results and provide corporate update on thursday, may 11, 2023

SEATTLE , May 1, 2023 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commer...

May 1, 2023, 4:46 pm

Predicine to introduce predicinealert™ mrd assay and present two ctdna studies in genitourinary cancers at aua 2023 annual meeting

HAYWARD, Calif., April 28, 2023 (GLOBE NEWSWIRE) — Predicine, a global molecular insights company, announced today that it will present two studies ...

April 28, 2023, 9:42 pm

Hillstream biopharma announces pricing of public offering

BRIDGEWATER, N.J., April 27, 2023 (GLOBE NEWSWIRE) — Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or the “Company”), a biotechnol...

April 28, 2023, 1:50 am

Qualigen therapeutics, inc. receives nasdaq notice regarding delayed form 10-k filing

CARLSBAD, Calif., April 21, 2023 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified l...

April 21, 2023, 9:46 pm


Search within

Pages Search Results: